The coming changes in the German pharma market are not quite as dour as the article you posted makes them sound. About 25% of the German pharma market is already being handled through government tenders, and this portion of the market will not undergo any changes.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”